Peptide Science & Safety: FAQ

Twenty-odd questions on peptides, answered carefully

Somewhere between the gym forums and the anti-ageing clinics, peptide science got ahead of the public conversation. I've spent the last few months building the reference library for this site, and the questions I keep flagging for fact-checking cluster hard around three things: what peptides actually are at a chemistry level, what the TGA says about them, and whether the products being sold online are legal. The short version is: it's complicated, and a lot of what's being spruiked out there sits in genuinely uncertain legal territory.

What follows is a plain-language Q&A built from primary sources. Every answer sticks to mechanism, classification, and regulation. Nothing here is health advice.

The chemistry basics

What is a peptide?

A peptide is a short chain of amino acids linked by peptide bonds , the covalent bonds that form when the carboxyl group of one amino acid reacts with the amino group of the next. By convention, chains of fewer than roughly 50 amino acids are called peptides; longer chains become proteins. The boundary is fuzzy and chemists argue about it.

How are peptides different from proteins?

Size and, usually, structural complexity. Insulin is a peptide (51 amino acids). Haemoglobin is a protein. Both are built from the same 20-odd standard amino acids via the same bond chemistry. The functional difference in a biological context often comes down to whether the molecule can fold into a complex tertiary structure , proteins generally do, short peptides generally don't.

Are peptides naturally occurring?

Yes. Many well-characterised biological signalling molecules are peptides , glucagon, oxytocin, and certain neuropeptides among them. The body synthesises peptides constantly; they're not exotic. What varies enormously is whether a given synthetic or isolated peptide has been through the clinical testing required for therapeutic registration.

What does "synthetic peptide" mean?

A peptide manufactured outside a living system, typically by solid-phase peptide synthesis (SPPS). The sequence may mirror a naturally occurring peptide exactly, or it may be a modified analogue designed for increased stability or receptor selectivity. The chemistry is well-established; the regulatory status of any specific synthetic peptide depends entirely on what it is and how it's classified.

What is a GLP-1 receptor agonist?

A GLP-1 receptor agonist is a molecule that binds to and activates the glucagon-like peptide-1 receptor. GLP-1 is an endogenous incretin hormone. Several approved pharmaceutical GLP-1 receptor agonists are registered therapeutic goods in Australia; they are prescription-only under Schedule 4 of the Poisons Standard. The receptor pharmacology has been studied extensively; the clinical picture around approved agents is reasonably well characterised, but that characterisation does not transfer automatically to unapproved analogues.

How peptides behave in the body

Why are many peptides injected rather than taken orally?

Because the gastrointestinal tract breaks peptide bonds efficiently. Proteases in the stomach and small intestine cleave peptide chains into their constituent amino acids before they can be absorbed intact. Subcutaneous injection bypasses first-pass digestion and delivers the molecule into subcutaneous tissue, from which it enters systemic circulation more intact. This is the same reason insulin is injected.

What does "bioavailability" mean for a peptide?

Bioavailability refers to the fraction of an administered dose that reaches systemic circulation in an unchanged, active form. For most unmodified peptides taken orally, bioavailability is very low, often less than 1-2%. Injectable routes yield substantially higher bioavailability, which is why the route of administration matters so much in peptide pharmacokinetics.

Does the body recognise synthetic peptides as foreign?

It depends on the sequence and molecular weight. Short synthetic peptides closely matching endogenous sequences are often tolerated without a significant immune response. Larger or heavily modified sequences carry a higher risk of immunogenicity. This is an active area of pharmaceutical research and one of the reasons that clinical trials, rather than forum anecdote; matter for characterising the safety profile of any given peptide.

Australian regulation: what the TGA actually says

Are peptide products regulated in Australia?

Yes. Therapeutic goods (including peptides intended to influence physiological processes) are regulated by the Therapeutic Goods Administration (TGA) under the Therapeutic Goods Act 1989. A product must be either registered or listed on the Australian Register of Therapeutic Goods (ARTG) before it can be legally supplied in Australia, unless a specific exemption applies.

What is the TGA's position on unapproved peptides being sold online?

The TGA has stated explicitly and repeatedly that many peptides marketed for performance enhancement, body composition, and anti-ageing are unapproved therapeutic goods. Supplying unapproved therapeutic goods in Australia is illegal. The TGA has issued multiple public warnings and taken enforcement action against suppliers. The relevant guidance is available directly at tga.gov.au.

Can a doctor prescribe unapproved peptides in Australia?

Unapproved therapeutic goods can, in specific circumstances, be accessed through the TGA's Special Access Scheme (SAS) or via an Authorised Prescriber arrangement. These pathways are tightly regulated. They are not a general licence for prescribing whatever a patient requests, both involve specific TGA oversight and apply only where no registered alternative is suitable. The prescribing doctor bears significant regulatory responsibility.

Where do approved peptide-based drugs sit in the Poisons Standard?

It varies by substance. Most approved peptide pharmaceuticals in Australia are Schedule 4 (Prescription Only). Some, depending on abuse potential and other scheduling criteria, may sit at Schedule 8 (Controlled Drug). The scheduling of any specific molecule is determined by the TGA delegate and published in the current Poisons Standard, checking the current Standard directly is the only reliable method, as schedules can change.

What manufacturing standards apply to pharmaceutical-grade peptides?

Any peptide manufactured as a therapeutic good for the Australian market must comply with Good Manufacturing Practice (GMP) requirements. GMP covers facility standards, testing, batch records, and quality systems. Products sourced outside this framework; including many sold via unregulated online channels, cannot be verified as meeting these standards, which has direct implications for purity, potency, and contamination risk.

Are peptides the same as anabolic steroids from a legal perspective?

No, but some peptides used in sport are prohibited substances under the World Anti-Doping Agency (WADA) Code, and separately, their supply may constitute an offence under Australian law if they are unapproved therapeutic goods. The legal question and the sporting-sanctions question are distinct. Neither question cancels out the other.

Safety and research questions

What are the known risks associated with unapproved peptide products?

Without approved status and GMP compliance, risks include: unknown purity (contaminants, residual solvents, bacterial endotoxins), incorrect potency (under- or over-dosed active ingredient), undisclosed additives, and absence of pharmacovigilance data. Beyond product quality, even a chemically pure peptide administered outside a clinical setting lacks the safety monitoring that characterised trial participants had. The TGA's published enforcement actions document these concerns in specific terms.

Does peer-reviewed research exist on peptides?

Yes, a large body of it, indexed on PubMed/NCBI. The state of evidence varies enormously between molecules. Some peptides (those in approved pharmaceuticals) have Phase III trial data, post-market surveillance, and systematic reviews. Others have early-phase animal data or in-vitro studies only. The existence of research is not, by itself, evidence that a substance is safe or effective for self-administration outside a clinical context. Study design, sample size, and trial phase all matter. I always reckon the abstract is the last place to stop reading; methodology is where the questions live.

Can peptides interact with other medicines?

Potentially. Interaction mechanisms depend on the specific peptide and the specific co-administered medicine. This is a question for a prescribing doctor or clinical pharmacist with access to a patient's full medication list, it cannot be answered generically.

What should someone do if they've already purchased an unapproved peptide product?

That's a question for a medical professional, not a FAQ page. The TGA website (tga.gov.au) has consumer guidance on reporting adverse events and on understanding the risks of unapproved goods. For genuine health concerns, the appropriate pathway is a GP or pharmacist.

Peptides and related molecules

Are peptides related to cannabinoids?

Not directly, in structural terms, cannabinoids and peptides are chemically distinct classes. There is, however, some research interest in interactions between peptide signalling systems and the endocannabinoid system, particularly around endogenous peptides that may modulate CB1 and CB2 receptor activity. This is an area of basic science; it doesn't translate to clinical guidance.

Is there overlap between peptide-based pharmaceuticals and plant-based medicine?

Some. Certain phytomedicine research examines plant-derived peptides or peptide-like compounds. But "plant-based peptide" and "pharmaceutical peptide" occupy very different regulatory categories, and a botanical origin doesn't exempt a substance from therapeutic goods regulation in Australia.

What about peptides advertised as research chemicals?

The "research chemical" label is not a regulatory category under Australian law. It doesn't exempt a substance from the Therapeutic Goods Act. If a substance meets the definition of a therapeutic good, it is regulated as one regardless of how it's labelled. This is one area where the TGA has been clear, publicly and repeatedly.

Sources

• Peptides and regulation; Therapeutic Goods Administration (TGA), Australian Government
• Biochemistry of peptide bonds, National Center for Biotechnology Information (NCBI)
• Illegal and unapproved products, Therapeutic Goods Administration (TGA), Australian Government
• Prescription medicines in Australia; Australian Government Department of Health and Aged Care

, Tom Whitfield, Health librarian, references & fact-checking